The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Open accessAbstract
The discovery of interleukin (IL)-6 and its receptor subunits provided a foundation to understand the biology of a group of related cytokines: IL-12, IL-23, IL-27. These family members utilize shared receptors and cytokine subunits and influence the outcome of cancer, infection and inflammatory diseases. Consequently, many facets of their biology are being therapeutically targeted. Here we review the landmark discoveries in this field, the combinatorial biology inherent to this family and how patient data sets have underscored the critical role of these pathways in human disease. We present significant knowledge gaps, including how similar signals from these cytokines can mediate distinct outcomes, and discuss how a better understanding of the biology of the IL-12 family provides new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 5×
“For example, IL-6 utilizes STAT3 to promote inflammation (Bettelli et al., 2006), but STAT3 is required for IL-6 and IL-27 to induce IL-10 (Pot et al., 2011; Stumhofer et al., 2007).”
InfluentialThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 2×
“Indeed, landmark studies showed that transfer of antigen-specific IL-23-driven IL-17-producing CD4+ T cells could induce EAE in mice, and that treatment of these mice with anti-IL-17 provided partial protection against disease (Langrish et al., 2005).”
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 4×
“IL-6 can also work in synergy with TGF-β to promote the development of naive CD4+ T cells into Th17 cells (Figure 3B) (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006).”
BackgroundInfluentialDevelopment of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 3×
“IL-6 can also work in synergy with transforming growth factor b (TGF-b) to promote the development of naive CD4+ T cells into Th17 cells (Figure 3B) (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006).”
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Self-citationHuman Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 1×
“One of the soluble factors produced by T cell hybrid clones or mitogen-stimulated T cells that was responsible for this effect was cloned and characterized as a stimulator of B cell growth, proliferation and antibody production (Hirano et al., 1986; Kishimoto, 2005).”
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 1×
“The generation of mice deficient in IL-6 affirmed its important role as an acute phase reactant and in innate resistance to bacterial challenges (Kopf et al., 1994).”
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Bcl6 mediates the development of T follicular helper cells
Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y.-H., & Dong, C. (2009) · Science · doi:10.1126/science.1176676 · Cited by 1,506
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., & Campbell, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1731 · Cited by 1,258
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,221
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Nurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., Wang, Y.-H., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.009 · Cited by 1,205
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · cited 17×
“Th17 cells that produce GM-CSF are present in the blood of healthy humans and MS patients (Kara et al., 2015), but in humans, IL-23 appears to limit GM-CSF production (Noster et al., 2014).”
InfluentialRequirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., et al. (1996) · Nature · doi:10.1038/382171a0 · Cited by 1,180
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 3×
“As noted earlier, IL-6 was subsequently linked to the development of Th17 cells (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006), while more recent reports in EAE have highlighted links between IL-23 and GM-CSF production by Th17 cells, which promotes the recruitment of inflammatory monocytes to the…”
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018 · cited 1×
“For example, the finding that IL-23p19−/− mice are highly resistant to cancer (Langowski et al., 2006) was unexpected and difficult to reconcile with the ability of IL-23”
Szabo, S. J., Dighe, A. S., Gubler, U., & Murphy, K. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.817 · Cited by 1,005
CD4 + Regulatory T Cells Control T H 17 Responses in a Stat3-Dependent Manner
Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., & Rudensky, A. Y. (2009) · Science · doi:10.1126/science.1172702 · Cited by 1,000 · cited 1×
“For example, signals from STAT3 (likely from IL-6) support a Treg cell population that limits Th17 responses (Chaudhry et al., 2009).”
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Self-citationHuman interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928 · cited 1×
“In a subset of patients with Castleman’s disease, blockade of IL-6 or its receptor limits B cell proliferation and has therapeutic effects (Figure 4A) (Beck et al., 1994; Yoshizaki et al., 1989).”
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
IL-35-mediated induction of a potent regulatory T cell population
Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1952 · Cited by 869
Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/422329 · Cited by 859
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S., & Sher, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6115 · Cited by 835
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., & Ghilardi, N. (2006) · Nature Immunology · doi:10.1038/ni1375 · Cited by 825
Role of T-bet in Commitment of T H 1 Cells Before IL-12-Dependent Selection
Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M., Kung, A. L., Cereb, N., Yao, T.-P., Yang, S. Y., et al. (2001) · Science · doi:10.1126/science.1059835 · Cited by 825
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804 · cited 2×
“…series of studies converged on the idea that IL-27 (as well as IL-6 and IL-12) can direct Th1, Th2 and Th17 cells to produce IL-10 that limits accessory cell responses during neuroinflammation (Figure 3C) (Awasthi et al., 2007; Batten et al., 2008; Fitzgerald et al., 2007; Stumhofer et al., 2007).”
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Liu, L., Okada, S., Kong, X.-F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 797
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O'Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 775
Self-citationIL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
Wang, R.-X., Yu, C.-R., Dambuza, I. M., Mahdi, R. M., Dolinska, M. B., Sergeev, Y. V., Wingfield, P. T., Kim, S.-H., & Egwuagu, C. E. (2014) · Nature Medicine · doi:10.1038/nm.3554 · Cited by 733
Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1797 · Cited by 720
Current and emerging therapeutic targets for IBD
Neurath, M. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.208 · Cited by 691
A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C.-Y., Gately, M. K., & Gubler, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14002 · Cited by 689
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Gordon, K. B., Strober, B., Lebwohl, M., Augustin, M., Blauvelt, A., Poulin, Y., Papp, K. A., Sofen, H., Puig, L., Foley, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31713-6 · Cited by 678
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1755 · Cited by 673
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R., Shellito, J. E., Bagby, G. J., Nelson, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050193 · Cited by 605
Niedbala, W., Wei, X., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737810 · Cited by 588
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells
Mathur, A. N., Chang, H.-C., Zisoulis, D. G., Stritesky, G. L., Yu, Q., O’Malley, J. T., Kapur, R., Levy, D. E., Kansas, G. S., & Kaplan, M. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4901 · Cited by 555
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6621 · Cited by 537
Eto, D., Lao, C., DiToro, D., Barnett, B., Escobar, T. C., Kageyama, R., Yusuf, I., & Crotty, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017739 · Cited by 533
Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T. W., Yoshimura, A., & Yoshida, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4886 · Cited by 530
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 508
Interleukin 12: still a promising candidate for tumor immunotherapy?
Lasek, W., Zagożdżon, R., & Jakobisiak, M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1523-1 · Cited by 495
The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection
Villarino, A., Hibbert, L., Lieberman, L., Wilson, E., Mak, T., Yoshida, H., Kastelein, R. A., Saris, C., & Hunter, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00300-5 · Cited by 484
Self-citationBoniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Moschen, A. R., Tilg, H., & Raine, T. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0084-8 · Cited by 473
Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A., & Alber, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260722 · Cited by 469
Lucas, S., Ghilardi, N., Li, J., & de Sauvage, F. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536517100 · Cited by 459
Feagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
The composition and signaling of the IL-35 receptor are unconventional
Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2227 · Cited by 450
Self-citationSOCS3 regulates the plasticity of gp130 signaling
Lang, R., Pauleau, A.-L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., & Murray, P. J. (2003) · Nature Immunology · doi:10.1038/ni932 · Cited by 439
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
Chihara, N., Madi, A., Kondo, T., Zhang, H., Acharya, N., Singer, M., Nyman, J., Marjanovic, N. D., Kowalczyk, M. S., Wang, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0206-z · Cited by 438 · cited 2×
“This work has continued to evolve with recent reports that IL-27 can support the development of T cell populations that express a diverse module of inhibitory receptors in murine models of cancer and infection (Chihara et al., 2018; DeLong et al., 2019).”
Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
Gillessen, S., Carvajal, D., Ling, P., Podlaski, F. J., Stremlo, D. L., Familletti, P. C., Gubler, U., Presky, D. H., Stern, A. S., & Gately, M. K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250133 · Cited by 436
Altare, F., Lammas, D., Revy, P., Jouanguy, E., Döffinger, R., Lamhamedi, S., Drysdale, P., Scheel-Toellner, D., Girdlestone, J., Darbyshire, P., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4950 · Cited by 413
Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T., & Kishimoto, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11349 · Cited by 408
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection
Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00206-0 · Cited by 406 · cited 1×
“that it was required for Th1 polarization during infection with Listeria monocytogenes or Leishmania major (Chen et al., 2000; Yoshida et al., 2001).”
Gran, B., Zhang, G.-X., Yu, S., Li, J., Chen, X.-H., Ventura, E. S., Kamoun, M., & Rostami, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7104 · Cited by 405
Mashayekhi, M., Sandau, M. M., Dunay, I. R., Frickel, E. M., Khan, A., Goldszmid, R. S., Sher, A., Ploegh, H. L., Murphy, T. L., Sibley, L. D., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.008 · Cited by 403
Development of Th1-type immune responses requires the type I cytokine receptor TCCR
Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M.-H., Gurney, A., Grewal, I. S., & de Sauvage, F. J. (2000) · Nature · doi:10.1038/35038103 · Cited by 402
Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.
Ling, P., Gately, M. K., Gubler, U., Stern, A. S., Lin, P., Hollfelder, K., Su, C., Pan, Y. C. E., & Hakimi, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.116 · Cited by 399
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15751 · Cited by 386
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Heink, S., Yogev, N., Garbers, C., Herwerth, M., Aly, L., Gasperi, C., Husterer, V., Croxford, A. L., Möller-Hackbarth, K., Bartsch, H. S., et al. (2017) · Nature Immunology · doi:10.1038/ni.3632 · Cited by 386
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A., Bonneau, R., Scherl, E. J., & Littman, D. R. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140678 · Cited by 383
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Sockolosky, J. T., Trotta, E., Parisi, G., Picton, L., Su, L. L., Le, A. C., Chhabra, A., Silveria, S. L., George, B. M., King, I. C., et al. (2018) · Science · doi:10.1126/science.aar3246 · Cited by 382
Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215751 · Cited by 346
Hall, A. O., Beiting, D. P., Tato, C., John, B., Oldenhove, G., Lombana, C. G., Pritchard, G. H., Silver, J. S., Bouladoux, N., Stumhofer, J. S., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.014 · Cited by 344
Self-citationNarazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Devergne, O., Hummel, M., Koeppen, H., Le Beau, M. M., Nathanson, E. C., Kieff, E., & Birkenbach, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1143-1153.1996 · Cited by 341
Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N., deSauvage, F. J., Lund, F. E., & Cooper, A. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052545 · Cited by 335
IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
Diveu, C., McGeachy, M. J., Boniface, K., Stumhofer, J. S., Sathe, M., Joyce-Shaikh, B., Chen, Y., Tato, C. M., McClanahan, T. K., de Waal Malefyt, R., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801162 · Cited by 333
Self-citationDevergne, O., Birkenbach, M., & Kieff, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12041 · Cited by 326
Beck, J. T., Hsu, S.-M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S., & Barlogie, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300904 · Cited by 322
Sofen, H., Smith, S., Matheson, R. T., Leonardi, C. L., Calderon, C., Brodmerkel, C., Li, K., Campbell, K., Marciniak, S. J., Wasfi, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.025 · Cited by 320
IL-27 and IFN- α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12R β 2 in Naive T Cells
Hibbert, L., Pflanz, S., de Waal Malefyt, R., & Kastelein, R. A. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900360708632 · Cited by 318
Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021769 · Cited by 312
Harker, J. A., Lewis, G. M., Mack, L., & Zuniga, E. I. (2011) · Science · doi:10.1126/science.1208421 · Cited by 311
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311
Choi, Y. S., Eto, D., Yang, J. A., Lao, C., & Crotty, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203032 · Cited by 307
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Gordon, K. B., Duffin, K. C., Bissonnette, R., Prinz, J. C., Wasfi, Y., Li, S., Shen, Y.-K., Szapary, P., Randazzo, B., & Reich, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501646 · Cited by 306
Chua, A. O., Chizzonite, R., Desai, B. B., Truitt, T. P., Nunes, P., Minetti, L. J., Warrier, R. R., Presky, D. H., Levine, J. F., Gately, M. K., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.1.128 · Cited by 306
Zhang, G.-X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M., & Rostami, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2153 · Cited by 305
Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.
Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., Kishimoto, T., & Taga, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2285 · Cited by 299
Tripp, C. S., Gately, M. K., Hakimi, J., Ling, P., & Unanue, E. R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1883 · Cited by 297
Wiekowski, M. T., Leach, M. W., Evans, E. W., Sullivan, L., Chen, S.-C., Vassileva, G., Bazan, J. F., Gorman, D. M., Kastelein, R. A., Narula, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7563 · Cited by 295
Yap, G., Pesin, M., & Sher, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.628 · Cited by 291
Albanesi, C., Scarponi, C., Cavani, A., Federici, M., Nasorri, F., & Girolomoni, G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00041.x · Cited by 286
Immunological activity of thymus and thoracic-duct lymphocytes.
Mitchell, G. F., & Miller, J. F. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.59.1.296 · Cited by 284
Kauffman, C. L., Aria, N., Toichi, E., McCormick, T. S., Cooper, K. D., Gottlieb, A. B., Everitt, D. E., Frederick, B., Zhu, Y., Graham, M. A., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23448.x · Cited by 279
The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer
Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rüde, E., & Germann, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230923 · Cited by 279
Schulz, E. G., Mariani, L., Radbruch, A., & Höfer, T. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.013 · Cited by 279
In Vivo Regulation of Bcl6 and T Follicular Helper Cell Development
Poholek, A. C., Hansen, K., Hernandez, S. G., Eto, D., Chandele, A., Weinstein, J. S., Dong, X., Odegard, J. M., Kaech, S. M., Dent, A. L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904023 · Cited by 278
IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L. M., Anderson, D. E., & Weiner, H. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900568 · Cited by 276
Hamano, S., Himeno, K., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00298-x · Cited by 264
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., & Garcia, K. C. (2001) · Science · doi:10.1126/science.1058308 · Cited by 261
Collison, L. W., Pillai, M. R., Chaturvedi, V., & Vignali, D. A. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803646 · Cited by 259
Hirahara, K., Ghoreschi, K., Yang, X.-P., Takahashi, H., Laurence, A., Vahedi, G., Sciumè, G., Hall, A. O., Dupont, C. D., Francisco, L. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.024 · Cited by 254
Self-citationThe Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases
Tanner, J. W., Chen, W., Young, R. L., Longmore, G. D., & Shaw, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6523 · Cited by 247
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Noster, R., Riedel, R., Mashreghi, M.-F., Radbruch, H., Harms, L., Haftmann, C., Chang, H.-D., Radbruch, A., & Zielinski, C. E. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008706 · Cited by 234
Pleiotropy and redundancy: T cell-derived lymphokines in the immune response
Paul, W. E. (1989) · Cell · doi:10.1016/0092-8674(89)90121-9 · Cited by 231
A Protective and Agonistic Function of IL-12p40 in Mycobacterial Infection
Hölscher, C., Atkinson, R. A., Arendse, B., Brown, N., Myburgh, E., Alber, G., & Brombacher, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6957 · Cited by 229
In vivo production and function of IL-12 p40 homodimers
Heinzel, F. P., Hujer, A. M., Ahmed, F. N., & Rerko, R. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4381 · Cited by 229
Kleinschek, M. A., Muller, U., Brodie, S. J., Stenzel, W., Kohler, G., Blumenschein, W. M., Straubinger, R. K., McClanahan, T., Kastelein, R. A., & Alber, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1098 · Cited by 227
Kamiya, S., Owaki, T., Morishima, N., Fukai, F., Mizuguchi, J., & Yoshimoto, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3871 · Cited by 220
Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J., & Maraskovsky, E. (2005) · Blood · doi:10.1182/blood-2004-05-1718 · Cited by 218
IL-27 Limits IL-2 Production during Th1 Differentiation
Villarino, A. V., Stumhofer, J. S., Saris, C. J. M., Kastelein, R. A., de Sauvage, F. J., & Hunter, C. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.237 · Cited by 216
Self-citationClinical improvement in psoriasis with specific targeting of interleukin-23
Kopp, T., Riedl, E., Bangert, C., Bowman, E. P., Greisenegger, E., Horowitz, A., Kittler, H., Blumenschein, W. M., McClanahan, T. K., Marbury, T., et al. (2015) · Nature · doi:10.1038/nature14175 · Cited by 210
Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells
Batten, M., Kljavin, N. M., Li, J., Walter, M. J., de Sauvage, F. J., & Ghilardi, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2752 · Cited by 208
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R. S., & Neurath, M. F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.040 · Cited by 207
Boisson-Dupuis, S., Ramirez-Alejo, N., Li, Z., Patin, E., Rao, G., Kerner, G., Lim, C. K., Krementsov, D. N., Hernandez, N., Ma, C. S., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau8714 · Cited by 207
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
Zhu, C., Sakuishi, K., Xiao, S., Sun, Z., Zaghouani, S., Gu, G., Wang, C., Tan, D. J., Wu, C., Rangachari, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7072 · Cited by 206
Batten, M., Ramamoorthi, N., Kljavin, N. M., Ma, C. S., Cox, J. H., Dengler, H. S., Danilenko, D. M., Caplazi, P., Wong, M., Fulcher, D. A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100064 · Cited by 206
Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., & Kishimoto, T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05815.x · Cited by 204
Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23
Martínez-Barricarte, R., Markle, J. G., Ma, C. S., Deenick, E. K., Ramírez-Alejo, N., Mele, F., Latorre, D., Mahdaviani, S. A., Aytekin, C., Mansouri, D., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau6759 · Cited by 204
IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection
Park, A. Y., Hondowicz, B. D., & Scott, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.896 · Cited by 203
A Role for IL-27 in Early Regulation of Th1 Differentiation
Owaki, T., Asakawa, M., Morishima, N., Hata, K., Fukai, F., Matsui, M., Mizuguchi, J., & Yoshimoto, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2191 · Cited by 203
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Narazaki, M., & Kishimoto, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113528 · Cited by 201
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 196
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Hanson, M. L., Hixon, J. A., Li, W., Felber, B. K., Anver, M. R., Stewart, C. A., Janelsins, B. M., Datta, S. K., Shen, W., McLean, M. H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.060 · Cited by 195
Jones, G. W., McLoughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., Scheller, J., Williams, A. S., Rose-John, S., Topley, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901528 · Cited by 189
Puel, A., Picard, C., Lorrot, M., Pons, C., Chrabieh, M., Lorenzo, L., Mamani-Matsuda, M., Jouanguy, E., Gendrel, D., & Casanova, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.647 · Cited by 188
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
Wirtz, S., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S., & Neurath, M. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060471 · Cited by 186
Hirahara, K., Onodera, A., Villarino, A. V., Bonelli, M. M., Sciumè, G., Laurence, A. D. J., Sun, H., Brooks, S. R., Vahedi, G., Shih, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.014 · Cited by 184
Self-citationA role for IL-27p28 as an antagonist of gp130-mediated signaling
Stumhofer, J. S., Tait, E. D., III, W. J. Q., Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1957 · Cited by 184
Self-citationGearing, D. P., & Cosman, D. (1991) · Cell · doi:10.1016/0092-8674(91)90131-h · Cited by 181
Su, Z., & Stevenson, M. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1348 · Cited by 176
Hirano, T., Matsuda, T., & Nakajima, K. (1994) · STEM CELLS · doi:10.1002/stem.5530120303 · Cited by 176
Sun, J., Dodd, H., Moser, E. K., Sharma, R., & Braciale, T. J. (2011) · Nature Immunology · doi:10.1038/ni.1996 · Cited by 175
Prostaglandin E2 induces IL‐23 production in bone marrow‐derived dendritic cells
Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E., & Ganea, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-1367fje · Cited by 171
Khayrullina, T., Yen, J.-H., Jing, H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.721 · Cited by 170
New treatment options for inflammatory bowel diseases
Verstockt, B., Ferrante, M., Vermeire, S., & Van Assche, G. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1449-z · Cited by 170
IL-23 Provides a Limited Mechanism of Resistance to Acute Toxoplasmosis in the Absence of IL-12
Lieberman, L. A., Cardillo, F., Owyang, A. M., Rennick, D. M., Cua, D. J., Kastelein, R. A., & Hunter, C. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1887 · Cited by 169
Self-citationPositive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation
Villarino, A. V., Larkin, J., Saris, C. J. M., Caton, A. J., Lucas, S., Wong, T., de Sauvage, F. J., & Hunter, C. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7684 · Cited by 166
Self-citationCutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
Briso, E. M., Dienz, O., & Rincon, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7102 · Cited by 165
Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27
Pot, C., Apetoh, L., Awasthi, A., & Kuchroo, V. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.003 · Cited by 165
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
Yan, J., Smyth, M. J., & Teng, M. W. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 161
IL-27 Induces a Th1 Immune Response and Susceptibility to Experimental Arthritis
Cao, Y., Doodes, P. D., Glant, T. T., & Finnegan, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.922 · Cited by 159
T cell-intrinsic role of IL-6 signaling in primary and memory responses
Nish, S. A., Schenten, D., Wunderlich, F. T., Pope, S. D., Gao, Y., Hoshi, N., Yu, S., Yan, X., Lee, H. K., Pasman, L., et al. (2014) · eLife · doi:10.7554/elife.01949 · Cited by 159
Interleukin 27 attenuates collagen-induced arthritis
Niedbała, W., Cai, B., Wei, X., Patakas, A., Leung, B. P. L., McInnes, I. B., & Liew, F. Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083360 · Cited by 153
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Sweeney, C. M., Lonergan, R., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J., Costelloe, L., Tubridy, N. J., Mills, K. H. G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.007 · Cited by 152
An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell–suppressive function and therapeutic efficacy
Do, J., Visperas, A., Sanogo, Y. O., Bechtel, J. J., Dvorina, N., Kim, S. M., Jang, E., Stohlman, S. A., Shen, B., Fairchild, R. L., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.45 · Cited by 151
Crabé, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Bigouagou, U. M., Lefouili, F., Cognet, I., Ferlin, W. G., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901464 · Cited by 150
Chan, I. H., JAIN, R. K., Tessmer, M. S., Gorman, D., Mangadu, R., Sathe, M., Vives, F., Moon, C., Penaflor, E., Turner, S. P., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.101 · Cited by 145
Smolen, J. S., Agarwal, S. K., Ilivanova, E. P., Xu, X. L., Ye, M., Zhuang, Y., Nnane, I. P., Radziszewski, W., Greenspan, A. J., Beutler, A. M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209831 · Cited by 144
Cloning and Characterization of a Novel Class I Cytokine Receptor
Sprecher, C. A., Grant, F. J., Baumgartner, J. W., Presnell, S., Schrader, S. K., Yamagiwa, T., Whitmore, T. E., O’Hara, P. J., & Foster, D. F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8576 · Cited by 143
Bloch, Y., Bouchareychas, L., Merceron, R., Składanowska, K., den Bossche, L. V., Detry, S., Govindarajan, S., Elewaut, D. S., Haerynck, F., Dullaers, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.12.008 · Cited by 143
IL-6: a cytokine at the crossroads of autoimmunity
Jones, B. E., Maerz, M. D., & Buckner, J. H. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.002 · Cited by 142
Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness
Tsai, Y., & Tsai, T. (2017) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17735756 · Cited by 141
Smolen, J. S., Weinblatt, M. E., Sheng, S., Zhuang, Y., & Hsu, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205137 · Cited by 139
Proteolytic Cleavage Governs Interleukin-11 Trans-signaling
Lokau, J., Nitz, R., Agthe, M., Monhasery, N., Aparicio-Siegmund, S., Schumacher, N., Wolf, J., Möller‐Hackbarth, K., Waetzig, G. H., Grötzinger, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.053 · Cited by 137
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Kopp, T., Lenz, P., Bello-Fernández, C., Kastelein, R. A., Kupper, T. S., & Stingl, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5438 · Cited by 133
Cited by
Harnessing cytokines and chemokines for cancer therapy
Propper, D. J., & Balkwill, F. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00588-9 · Cited by 989
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
The cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 696
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Ghoreschi, K., Balato, A., Enerbäck, C., & Sabat, R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00184-7 · Cited by 668
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Sun, Q., Hong, Z., Zhang, C., Wang, L., Han, Z., & Ma, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01522-4 · Cited by 598
Metadata
- Authors
- Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 50
- Issue
- 4
- Pages
- 851-870
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2938380387
- Cited by
- 482
- References
- 280
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.